WHO recommends use of two antibody drugs for Ebola treatments, calls for improved access
August 19, 2022 The World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics, with new strong recommendations for the use of two monoclonal antibodies, while …
WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs
Aug. 12, 2021 The World Health Organization (WHO) has announced the next phase in its Solidarity trial that will enroll hospitalized patients to test three new COVID-19 drugs. These therapies…
India’s Scammers Profit From COVID-19 Misery
June 4, 2021 From fake medicines to fire extinguishers disguised as oxygen cylinders and recycled personal protective equipment, India’s coronavirus hell has been lucrative for its ever-inventive army of scammers,…
WHO warns against use of remdesivir for COVID-19 patients
World Health Organisation (WHO) recommended on Friday that the anti-viral drug remdesivir should not be used for hospitalised COVID-19 patients, arguing that trials had failed to prove that the treatment…
Remdesivir turns out to do little to prevent deaths from COVID-19 – WHO study
The antiviral drug Remdesivir, considered one of the most promising COVID-19 treatments, turns out to do little to prevent deaths from the disease, according to a WHO-backed study. Remdesivir, which…
President Trump may likely be discharged on Monday
President Trump may be discharged from the hospital on Monday, his physician has told reporters. Doctors have said that President Donald Trump could be discharged as early as Monday to…
COVID-19: Remdesivir gets conditional EU clearance, becomes region’s first authorised therapy to treat virus
The European Commission, EU, said on Friday it had given conditional approval for the use of antiviral remdesivir in severe COVID-19 patients following an accelerated review process, making it the…
EU gives green light for use of Remdesivir, first COVID-19 drug
The first drug to treat severe cases of COVID-19 in the EU on Friday was given the green light, with the European Commission approving remdesivir. The EU’s Health Commissioner, Stella…
WHO declines comment on remdesivir in COVID-19 treatment
A top World Health Organization official declined comment on Wednesday on reports that Gilead Science’s remdesivir could help treat COVID-19, the respiratory disease caused by the novel coronavirus, but said…